Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial

BACKGROUND: The failure of cholesteryl ester transfer protein inhibitor torcetrapib was associated with an off‐target increase in plasma aldosterone. We sought to evaluate the impact of evacetrapib on plasma aldosterone level and determine the association between plasma aldosterone level and major a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anirudh, Patel, Divyang R., Brennan, Danielle M., Wolski, Kathy E., Lincoff, A. Michael, Ruotolo, Giacomo, McErlean, Ellen, Weerakkody, Govinda, Riesmeyer, Jeffrey S., Nicholls, Stephen J., Nissen, Steven E., Menon, Venu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912956/
https://www.ncbi.nlm.nih.gov/pubmed/31752637
http://dx.doi.org/10.1161/JAHA.119.013790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912956/
https://www.ncbi.nlm.nih.gov/pubmed/31752637
http://dx.doi.org/10.1161/JAHA.119.013790

Ejemplares similares